Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Clinical features of 314 patients with relapsing-remitting multiple sclerosis].
Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG.
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.
Paediatric multiple sclerosis: a qualitative study of families' diagnosis experiences.
Voluntary wheel running delays disease onset and reduces pain hypersensitivity in early experimental autoimmune encephalomyelitis (EAE).
Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.
Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood.
Fibroblast Growth Factor-2 Enhanced The Recruitment of Progenitor Cells and Myelin Repair in Experimental Demyelination of Rat Hippocampal Formations.
Therapeutic Potential of the Modulation of Sphingosine 1 phosphate receptors.
Caffeine treatment aggravates secondary degeneration after spinal cord injury.
Mesenchymal stem cells of dental origin - their potential for anti-inflammatory and regenerative actions in brain and gut damage.
Multiple sclerosis: 7 T MRI reveals cortical lesions associated with disability in MS.
Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography.
[Animal model of neuromyelitis optica].
Systematic review of correlates and determinants of physical activity in persons with multiple sclerosis.
Ethyl-eicosapentaenoic acid ameliorates the clinical course of experimental allergic encephalomyelitis induced in dark agouti rats.
An update of teriflunomide for treatment of multiple sclerosis.
Bevacizumab is safe in acute relapses of neuromyelitis optica.
Headaches in multiple sclerosis patients might imply an inflammatorial process.
Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.
High Fat Diet Exacerbates Neuroinflammation in an Animal Model of Multiple Sclerosis by Activation of the Renin Angiotensin System.
Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis.
Acute-Phase Protein Hemopexin Is a Negative Regulator of Th17 Response and Experimental Autoimmune Encephalomyelitis Development.
Pharmacogenomics of interferon beta and glatiramer acetate response: A review of the literature.
Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis.
Pages
« first
‹ previous
…
600
601
602
603
604
605
606
607
608
…
next ›
last »